Haolong Lin

420 total citations
12 papers, 270 citations indexed

About

Haolong Lin is a scholar working on Oncology, Genetics and Immunology. According to data from OpenAlex, Haolong Lin has authored 12 papers receiving a total of 270 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Oncology, 3 papers in Genetics and 3 papers in Immunology. Recurrent topics in Haolong Lin's work include CAR-T cell therapy research (9 papers), Nanowire Synthesis and Applications (3 papers) and Virus-based gene therapy research (2 papers). Haolong Lin is often cited by papers focused on CAR-T cell therapy research (9 papers), Nanowire Synthesis and Applications (3 papers) and Virus-based gene therapy research (2 papers). Haolong Lin collaborates with scholars based in China, United States and Netherlands. Haolong Lin's co-authors include Wei Mu, Jianfeng Zhou, Jiali Cheng, Li Zhu, Liang Huang, Xiuxiu Yang, Zhenyu Dai, Chaohong Liu, Meng Wang and Jianwei Liu and has published in prestigious journals such as Science Translational Medicine, Frontiers in Immunology and Signal Transduction and Targeted Therapy.

In The Last Decade

Haolong Lin

10 papers receiving 267 citations

Peers

Haolong Lin
Nils W. Engel Germany
Nils Wellhausen United States
Nicholas F. Kuhn United States
Jaquelyn T. Zoine United States
Mi Shao China
Rebecca Epperly United States
Brent Chick United States
Sagar L. Patil United States
Chongbin He United States
Tianning Gu China
Nils W. Engel Germany
Haolong Lin
Citations per year, relative to Haolong Lin Haolong Lin (= 1×) peers Nils W. Engel

Countries citing papers authored by Haolong Lin

Since Specialization
Citations

This map shows the geographic impact of Haolong Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Haolong Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Haolong Lin more than expected).

Fields of papers citing papers by Haolong Lin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Haolong Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Haolong Lin. The network helps show where Haolong Lin may publish in the future.

Co-authorship network of co-authors of Haolong Lin

This figure shows the co-authorship network connecting the top 25 collaborators of Haolong Lin. A scholar is included among the top collaborators of Haolong Lin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Haolong Lin. Haolong Lin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
Lin, Haolong, et al.. (2025). Engineering CD5-targeting CAR-NK cells from peripheral blood for the treatment of CD5-positive hematological malignancies. Journal of Translational Medicine. 23(1). 409–409. 5 indexed citations
2.
Cheng, Jiali, Qiang Gao, Haolong Lin, et al.. (2025). CD5 ablation enhances persistence and antitumor potency of engineered T cells by mitigating exhaustion and promoting cytotoxicity. Journal for ImmunoTherapy of Cancer. 13(11). e012243–e012243.
3.
Lin, Haolong, Tao Wang, & Jia Wei. (2025). Strategic innovations: Tackling challenges of immunotherapy in acute myeloid leukemia. Chinese Journal of Cancer Research. 37(4). 490–504.
4.
Liu, Jiahao, Huayi Li, Yu Xia, et al.. (2025). Mitigating T cell DNA damage during PARP inhibitor treatment enhances antitumor efficacy. Science Translational Medicine. 17(797). eadr5861–eadr5861. 1 indexed citations
5.
Lin, Haolong, et al.. (2024). Antigen escape in CAR-T cell therapy: Mechanisms and overcoming strategies. Biomedicine & Pharmacotherapy. 178. 117252–117252. 41 indexed citations
6.
Lin, Haolong, et al.. (2024). Hepatitis B virus reactivation associated with CAR T-cell therapy. 3(1). 2 indexed citations
7.
Lin, Haolong, Shujia Zhang, Tong Ge, et al.. (2024). Optimizing the procedure for manufacturing clinical-grade genetically manipulated natural killer cells for adoptive immunotherapy. Cytotherapy. 27(2). 247–257. 3 indexed citations
8.
9.
Dai, Zhenyu, Wei Mu, Jiali Cheng, et al.. (2022). T cells expressing CD5/CD7 bispecific chimeric antigen receptors with fully human heavy-chain-only domains mitigate tumor antigen escape. Signal Transduction and Targeted Therapy. 7(1). 85–85. 65 indexed citations
10.
Lin, Haolong, Jiali Cheng, Wei Mu, Jianfeng Zhou, & Li Zhu. (2021). Advances in Universal CAR-T Cell Therapy. Frontiers in Immunology. 12. 744823–744823. 133 indexed citations
11.
12.
Hu, Xuelian, Haodong Cai, Yi Luo, et al.. (2020). Clinical and immunological features of platelet transfusion refractoriness in young patients with de novo acute myeloid leukemia. Cancer Medicine. 9(14). 4941–4948. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Nils W. Engel Breakdown of academic impact, for papers by Nils Wellhausen Breakdown of academic impact, for papers by Nicholas F. Kuhn Breakdown of academic impact, for papers by Jaquelyn T. Zoine Breakdown of academic impact, for papers by Mi Shao Breakdown of academic impact, for papers by Rebecca Epperly Breakdown of academic impact, for papers by Brent Chick Breakdown of academic impact, for papers by Sagar L. Patil Breakdown of academic impact, for papers by Chongbin He Breakdown of academic impact, for papers by Tianning Gu
Rankless by CCL
2026